关于我们
Sanacor’s first mission is to reverse diabetic cardiovascular disease. The company’s scientific foundation is based on nearly two decades of Widlansky Labs research and has received funding from the NIH and AHA. Cardiovascular disease is the #1 killer of diabetics. By 2045, over 500 million people will die from diabetic cardiovascular disease with an annual cost of care of $350 billion, and no effective treatments. The Widlansky lab discovered the underlying cause and developed a compound that safely reverses the disease by blocking FIS1 in human models. Sanacor also has begun early work to explore other areas where FIS1 is implicated such as diabetic kidney and eye disease, neurodegeneration, oncology and rare mitochondrial diseases.
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Milwaukee，WI
- 类型
- 私人持股
- 创立
- 2023
地点
-
主要
获取路线
US，WI，Milwaukee，53217
Sanacor员工
动态
-
Thank you MKEStartup! https://lnkd.in/gGdYxWPH
Sanacor?is on a mission to reverse diabetic cardiovascular disease, tackling a condition that is one of the leading causes of death for people with diabetes—yet has no effective treatments. Co-founded by Saira Gonsalves Ramasastry and Michael Widlansky the Milwaukee-based startup is translating a groundbreaking scientific discovery into what could be a life-saving drug.
-
-
Proud to be an Audacious Capital portfolio company! https://lnkd.in/gNP-EVuh
Proud to support Sanacor and Saira Gonsalves Ramasastry, as they advance innovative treatments for diabetic cardiovascular disease - a devastating condition with no effective treatment options. Their work, grounded in nearly two decades of research and supported by organizations like the NIH and AHA, holds significant potential to improve patients’ lives and reduce expensive healthcare costs. This milestone investment from Venture Investors Health Fund highlights the importance of Sanacor’s approach and its potential to address unmet needs in healthcare. We’re excited to see the team take their lead program closer to clinical studies. Venture Investors Health Fund Backs Milwaukee Biotech Company Sanacor to Address Cardiometabolic… https://lnkd.in/guB_NQc2
-
We are so excited to partner with the Venture Investors in our next stage of growth! https://lnkd.in/guB_NQc2
-
Thank you to VentureStarters.com for selecting us for Healthcare Unicorn Night! Our company presentation can be viewed from minute 12. https://lnkd.in/gTWVnDBN
Unicorn Night! Watch 9 Life Sciences Startups Pitch @ Venture Starters
https://www.youtube.com/